identified a novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapeutic drugs through DNM1L dephosphorylation and mitochondrial translocation-mediated mitochondrial fission (12). Here, DNM1L is linked to breast carcinoma.